undamentalytics Newsletter
Sign in

Cbdmd, Inc. income statement

In fiscal 2025, Cbdmd, Inc. reported revenue of $19.2m, down 1.5% on the year before, operating income of −$2.2m (a -11.3% margin) and net income of −$2.0m, or −$1.09 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Sept 20162017Sept 20172018Sept 20182019Sept 20192020Sept 20202021Sept 20212022Sept 20222023Sept 20232024Sept 20242025Sept 2025LTMJun 2026
Revenue2402442443524191921
Cost of revenue21091614139779
Gross profit0301526302215121212
Operating income−4−1−2−15−18−20−78−22−3−2−3
Interest expense010————————
Net interest income——000−000−000
Income before tax——−2−4811−24−70−23−4−2−3
Income tax000−21−10000—
Net income−4−10−5113−23−70−23−4−2−3
Diluted EPS−$406.80−$136.80$0.00$0.00$100.80−$0.47−$446.40−$106.56−$14.29−$1.09—
Diluted shares (average)—13m———————4m—
EBITDA−4−1−2−15−17−19−77−22−3−2−3

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AXIL vs YCBDNHTC vs YCBDFTLF vs YCBDUG vs YCBD

More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies

Figures from Cbdmd, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cbdmd, Inc.